Changes in cardiac heparan sulfate proteoglycan expression and streptozotocin-induced diastolic dysfunction in rats
<p>Abstract</p> <p>Background</p> <p>Changes in the proteoglycans glypican and syndecan-4 have been reported in several pathological conditions, but little is known about their expression in the heart during diabetes. The aim of this study was to investigate in vivo hea...
Main Authors: | Cestari Ismar N, Mansur Antonio P, Nogueira Adriana, Salemi Vera MC, Matsuda Monique, Strunz Célia MC, Marquezini Monica V |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-04-01
|
Series: | Cardiovascular Diabetology |
Subjects: | |
Online Access: | http://www.cardiab.com/content/10/1/35 |
Similar Items
-
Exploiting Heparan Sulfate Proteoglycans in Human Neurogenesis—Controlling Lineage Specification and Fate
by: Chieh Yu, et al.
Published: (2017-10-01) -
An investigation of genetic polymorphisms in heparan sulfate proteoglycan core proteins and key modification enzymes in an Australian Caucasian multiple sclerosis population
by: Rachel K. Okolicsanyi, et al.
Published: (2020-05-01) -
What Are the Potential Roles of Nuclear Perlecan and Other Heparan Sulphate Proteoglycans in the Normal and Malignant Phenotype
by: Anthony J. Hayes, et al.
Published: (2021-04-01) -
The transmembrane heparan sulphate proteoglycan syndecan-4 is involved in establishment of the lamellar structure of the annulus fibrosus of the intervertebral disc
by: MC Beckett, et al.
Published: (2015-08-01) -
Heparan Sulfate Proteoglycans as Drivers of Neural Progenitors Derived From Human Mesenchymal Stem Cells
by: Rachel K. Okolicsanyi, et al.
Published: (2018-04-01)